+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Transfusion Diagnostics Market - Global Forecast 2026-2032- Product Image
Blood Transfusion Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Blood Transfusion Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010986
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Transfusion Diagnostics Market is projected to reach USD 4.44 Billion in 2026. It is expected to continue growing at a CAGR of 5.19%, reaching USD 6.03 Billion by 2032.

Blood transfusion diagnostics is the testing backbone that makes transfusion therapy safe, traceable, and clinically effective. The field spans ABO and RhD blood grouping, extended antigen typing, antibody screening and identification, compatibility testing, direct antiglobulin testing, and transfusion-transmitted infection screening using serology, immunohematology automation, molecular assays, and nucleic acid testing.

Demand is supported by surgery, oncology, trauma care, obstetrics, chronic anemia management, transplantation, and aging populations. According to the World Health Organization, more than 118 million blood donations are collected globally each year, yet access and testing capacity remain uneven across income groups and health systems. This creates a sustained need for reliable blood bank diagnostics, standardized quality systems, and scalable platforms that improve turnaround time without compromising patient safety.

Transformative Shifts in Blood Transfusion Diagnostics

The blood transfusion diagnostics landscape is shifting from manual, batch-based testing toward integrated, automated, and data-connected workflows. Blood centers and hospital transfusion services are prioritizing high-throughput immunohematology analyzers, automated crossmatching, electronic blood management systems, and molecular typing to reduce human error, strengthen traceability, and support complex patient populations.

Regulatory expectations are also reshaping adoption. Authorities in major markets require validated infectious disease screening, donor traceability, quality controls, and hemovigilance reporting. At the same time, demand for phenotype- and genotype-matched blood is increasing for patients with sickle cell disease, thalassemia, cancer, transplantation needs, and prior alloimmunization, moving diagnostics from basic compatibility testing to precision transfusion support.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to improve transfusion diagnostics through image interpretation, antibody identification support, predictive inventory management, and risk stratification for adverse transfusion reactions. AI-enabled decision support can help laboratories prioritize complex cases, detect testing inconsistencies, and forecast component demand based on procedure schedules, trauma patterns, historical utilization, and seasonal blood collection pressures.

The cumulative impact is operational as much as clinical. AI can reduce avoidable wastage, improve blood availability, and support standardized interpretation across decentralized networks. However, adoption depends on validated datasets, explainable models, cybersecurity, interoperability with laboratory information systems, and regulatory oversight to ensure that algorithmic recommendations strengthen, rather than replace, expert transfusion medicine judgment.

Key Regional Insights

Asia-Pacific is becoming a high-priority region as China, India, Japan, South Korea, and Australia expand hospital networks, cancer care, transplant programs, trauma systems, and national blood safety initiatives. The region’s scale creates strong demand for automated blood grouping, infectious disease screening, and molecular testing, while rural access gaps continue to support decentralized, cost-efficient diagnostics and training-backed quality programs.

North America and Europe remain advanced adoption centers due to mature blood bank infrastructure, stringent regulatory frameworks, broad use of automation, accreditation-driven quality systems, and established hemovigilance practices. Latin America is improving screening quality through public blood programs and private diagnostic investment, with Brazil and Mexico playing central roles in regional blood service modernization. The Middle East is supported by hospital modernization, tertiary care expansion, and GCC healthcare investment, while Africa’s opportunity is tied to strengthening voluntary donation systems, donor screening, cold-chain reliability, and access to standardized testing for transfusion-transmitted infections.

Key Group Insights

ASEAN demand is shaped by population growth, expanding universal health coverage, and modernization of hospital laboratories across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. Adoption varies widely across the group, making scalable, service-backed platforms important for both centralized blood centers and decentralized hospital transfusion services. GCC countries are investing in tertiary hospitals, trauma centers, medical tourism, and digital health infrastructure, strengthening demand for automated transfusion testing, donor screening, and connected blood bank information systems.

The European Union benefits from harmonized quality expectations, advanced immunohematology practices, and cross-border standards for blood safety, including strong attention to traceability and hemovigilance. BRICS countries combine large patient bases with rapidly expanding diagnostic infrastructure, particularly in China, India, and Brazil, where surgical volumes, chronic disease care, and public health investment support broader testing needs. G7 markets lead in premium automation, molecular typing, quality assurance, and AI-enabled workflow optimization, while NATO countries place additional emphasis on emergency preparedness, blood supply resilience, and interoperability across military and civilian medical systems.

Key Country Insights

The United States leads in advanced immunohematology automation, molecular blood typing, electronic crossmatch adoption, and transfusion-transmitted infection screening, supported by FDA-regulated blood safety requirements, accreditation systems, and large hospital networks. Canada emphasizes national blood system coordination, quality standardization, and equitable access across geographically dispersed populations, while Mexico and Brazil continue to upgrade donor screening, infectious disease testing, and regional blood bank networks to improve transfusion safety and availability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain rely on mature transfusion services, strong quality systems, established hemovigilance practices, and rising demand for matched blood in oncology, hematology, surgery, and chronic disease care. Russia maintains substantial public blood infrastructure with continued relevance for hospital-based transfusion support. China and India represent major growth engines because of population scale, surgical volume, cancer treatment expansion, maternal health needs, and increasing laboratory capacity. Japan, South Korea, and Australia show high automation uptake, quality control maturity, digital workflow integration, and strong clinical demand for precision transfusion practices.

Actionable Recommendations for Industry Leaders

Vendors should prioritize platforms that combine immunohematology automation, infectious disease screening, molecular typing, and digital connectivity. Product strategies should address both high-throughput reference laboratories and decentralized hospital blood banks, with flexible reagent menus, reliable service coverage, quality control support, and validation assistance tailored to local regulatory needs.

Commercial success will depend on partnerships with blood services, hospital networks, public health agencies, and laboratory information system vendors. Industry leaders should invest in AI-ready data architecture, cybersecurity, staff training, interoperability, and post-implementation evidence generation. In emerging markets, value-based models, reagent rental programs, remote support, and technical education can accelerate adoption while supporting sustainable blood safety improvements.

Research Methodology

The research methodology is developed through secondary research using publicly available and institutionally recognized sources, including the World Health Organization, national blood services, health authorities, regulatory agencies, peer-reviewed transfusion medicine literature, and standards organizations. The analysis considers donor collection patterns, transfusion safety requirements, technology adoption, healthcare infrastructure, clinical demand drivers, and regional disease burdens.

The methodology applies cross-validation across multiple source categories to avoid reliance on a single dataset. Qualitative industry signals are evaluated alongside documented clinical practices, regulatory requirements, and technology trends in blood grouping, compatibility testing, infectious disease screening, molecular diagnostics, automation, hemovigilance, and digital workflow management.

Conclusion

Blood transfusion diagnostics is moving from a compliance-centered testing function to a strategic enabler of safer, faster, and more personalized transfusion care. Automation, molecular typing, AI-enabled analytics, and connected laboratory systems are redefining how blood banks manage compatibility, safety, inventory, traceability, and clinical risk.

The strongest opportunities will emerge where proven diagnostic accuracy is paired with scalable service models, regulatory readiness, workforce enablement, and digital interoperability. Organizations that align product innovation with blood safety priorities, laboratory capacity constraints, and regional access needs will be best positioned to lead the next phase of the blood transfusion diagnostics market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Transfusion Diagnostics Market, by Product
7.1. Introduction
7.2. Consumables & Accessories
7.2.1. Microplates
7.2.2. Pipette Tips
7.3. Instruments
7.3.1. NAT Analyzers
7.3.2. Pathogen Reduction Systems
7.3.3. Serology Analyzers
7.4. Reagents & Kits
7.4.1. Amplification Reagents
7.4.2. Antibody Reagents
7.4.3. DNA Extraction Kits
8. Blood Transfusion Diagnostics Market, by Technology
8.1. Introduction
8.2. Nucleic Acid Testing
8.2.1. PCR
8.2.2. Transcription Mediated Amplification
8.3. Pathogen Reduction Technology
8.3.1. Amotosalen
8.3.2. Methylene Blue
8.3.3. Riboflavin
8.4. Serological Testing
8.4.1. ELISA
8.4.2. Lateral Flow Assays
9. Blood Transfusion Diagnostics Market, by Application
9.1. Introduction
9.2. Donation Screening
9.2.1. Immunohematology Testing
9.2.2. Viral Marker Screening
9.3. Quality Control
9.3.1. External Proficiency Testing
9.3.2. Internal Quality Control
9.4. Transfusion Safety
9.4.1. Blood Group Typing
9.4.2. Pathogen Inactivation
10. Blood Transfusion Diagnostics Market, by End User
10.1. Introduction
10.2. Hospital Blood Banks
10.3. Independent Laboratories
10.4. Research Institutes
11. Blood Transfusion Diagnostics Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Blood Transfusion Diagnostics Market, by Group
12.1. NATO
12.2. G7
12.3. BRICS
12.4. European Union
12.5. ASEAN
12.6. GCC
13. Blood Transfusion Diagnostics Market, by Country
13.1. China
13.2. United States
13.3. Japan
13.4. India
13.5. Germany
13.6. United Kingdom
13.7. Australia
13.8. France
13.9. South Korea
13.10. Italy
13.11. Canada
13.12. Russia
13.13. Brazil
13.14. Mexico
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Agena Bioscience, Inc.
15.3. BAG Health Care GmbH
15.4. Becton, Dickinson and Company
15.5. Bio-Rad Laboratories, Inc.
15.6. bioMérieux SA
15.7. Danaher Corporation
15.8. DIAGAST S.A.S.
15.9. DiaSorin S.p.A.
15.10. F. Hoffmann-La Roche Ltd
15.11. Fresenius Kabi AG
15.12. Grifols, S.A.
15.13. Hema Bioscience Inc.
15.14. HemoCue AB
15.15. Hologic, Inc.
15.16. Immucor, Inc.
15.17. Inno-Train Diagnostik GmbH
15.18. Ortho Clinical Diagnostics, Inc.
15.19. Quotient Limited
15.20. Siemens Healthineers AG
15.21. Sysmex Corporation
15.22. Thermo Fisher Scientific Inc.
15.23. Tulip Diagnostics (P) Ltd.
15.24. Werfen S.A.
List of Figures
FIGURE 1. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MICROPLATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MICROPLATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MICROPLATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PIPETTE TIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PIPETTE TIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL NAT ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL NAT ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL NAT ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PATHOGEN REDUCTION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PATHOGEN REDUCTION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PATHOGEN REDUCTION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SEROLOGY ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SEROLOGY ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SEROLOGY ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL AMPLIFICATION REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL AMPLIFICATION REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL AMPLIFICATION REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ANTIBODY REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ANTIBODY REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ANTIBODY REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DNA EXTRACTION KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DNA EXTRACTION KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DNA EXTRACTION KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TRANSCRIPTION MEDIATED AMPLIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TRANSCRIPTION MEDIATED AMPLIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TRANSCRIPTION MEDIATED AMPLIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PATHOGEN REDUCTION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PATHOGEN REDUCTION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PATHOGEN REDUCTION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL AMOTOSALEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL AMOTOSALEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL AMOTOSALEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL METHYLENE BLUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL METHYLENE BLUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL METHYLENE BLUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL RIBOFLAVIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL RIBOFLAVIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL RIBOFLAVIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL SEROLOGICAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SEROLOGICAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SEROLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DONATION SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL DONATION SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL DONATION SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNOHEMATOLOGY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNOHEMATOLOGY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNOHEMATOLOGY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL VIRAL MARKER SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL VIRAL MARKER SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL VIRAL MARKER SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL QUALITY CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL EXTERNAL PROFICIENCY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL EXTERNAL PROFICIENCY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL EXTERNAL PROFICIENCY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL INTERNAL QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL INTERNAL QUALITY CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL INTERNAL QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL TRANSFUSION SAFETY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL TRANSFUSION SAFETY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL TRANSFUSION SAFETY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PATHOGEN INACTIVATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PATHOGEN INACTIVATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PATHOGEN INACTIVATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HOSPITAL BLOOD BANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HOSPITAL BLOOD BANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HOSPITAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 123. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 124. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 125. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 126. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 127. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 128. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 129. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 130. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 132. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 133. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 134. EUROPE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 165. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 166. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 167. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 168. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 170. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 171. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 172. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 174. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 175. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 176. AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 194. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 195. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 196. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 197. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 199. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 200. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 201. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 203. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 204. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 205. NATO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 208. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 209. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 210. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 211. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 212. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 213. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 214. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 215. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 217. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 218. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 219. G7 BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 221. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 222. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 223. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 224. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 225. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 226. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 227. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 228. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 229. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 231. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 232. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 233. BRICS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 249. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 250. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 251. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 252. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 253. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 254. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 255. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 256. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 257. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 258. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 259. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 260. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 261. ASEAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 264. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 265. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 266. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 267. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 268. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 269. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 271. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 273. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 274. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 275. GCC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 277. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 278. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 279. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 280. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 281. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 282. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 283. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 284. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 286. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 288. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 289. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 290. CHINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 306. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 307. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 308. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 309. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 310. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 311. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 312. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 313. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 314. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 315. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 316. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2017-2032 (USD MILLION)
TABLE 317. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2017-2032 (USD MILLION)
TABLE 318. JAPAN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 321. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 322. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 323. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 324. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 325. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2017-2032 (USD MILLION)
TABLE 326. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 327. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2017-2032 (USD MILLION)
TABLE 328. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 329. INDIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2017-2032 (USD MILLION)
TABLE 330. INDIA BL

Companies Mentioned

  • Abbott Laboratories
  • Agena Bioscience, Inc.
  • BAG Health Care GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DIAGAST S.A.S.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Hema Bioscience Inc.
  • HemoCue AB
  • Hologic, Inc.
  • Immucor, Inc.
  • Inno-Train Diagnostik GmbH
  • Ortho Clinical Diagnostics, Inc.
  • Quotient Limited
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics (P) Ltd.
  • Werfen S.A.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.44 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.03 Billion
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Blood Transfusion Diagnostics - Global Strategic Business Report - Product Image

Blood Transfusion Diagnostics - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Blood Transfusion Devices Market - Global Forecast 2026-2032 - Product Image

Blood Transfusion Devices Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Blood Transfusion Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Blood Transfusion Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Blood Transfusion Diagnostics Market Report 2026 - Product Image

Blood Transfusion Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Blood Transfusion Diagnostics Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Technology, Application, End-User - Product Image

Blood Transfusion Diagnostics Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Technology, Application, End-User

  • Report
  • 160 Pages
  • Global
From

About the Transfusion Diagnostics Market

The Transfusion Diagnostics market is a segment of the In Vitro Diagnostics (IVD) industry. It focuses on the development and production of diagnostic tests used to detect and monitor blood-borne diseases, such as HIV, hepatitis, and syphilis. These tests are used to ensure the safety of blood transfusions and to monitor the health of blood donors. Transfusion Diagnostics tests are used in hospitals, blood banks, and other healthcare settings. The Transfusion Diagnostics market is driven by the increasing demand for safe and reliable blood transfusions, as well as the need for improved patient safety. Additionally, the development of new technologies, such as molecular diagnostics, has enabled the development of more accurate and sensitive tests. Some companies in the Transfusion Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Ortho Clinical Diagnostics, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.